Abstract: The present invention provides an IL13RA2-targeting herpes simplex virus in which an anti-IL13RA2 antibody or an antigen-binding fragment thereof is presented on the viral surface. Also provided is an anti-IL13RA2 antibody or an antigen-binding fragment thereof capable of specifically recognizing tumor cells.
| # | Name | Date |
|---|---|---|
| 1 | 202517029724-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [28-03-2025(online)].pdf | 2025-03-28 |
| 2 | 202517029724-STATEMENT OF UNDERTAKING (FORM 3) [28-03-2025(online)].pdf | 2025-03-28 |
| 4 | 202517029724-Sequence Listing in PDF [28-03-2025(online)].pdf | 2025-03-28 |
| 5 | 202517029724-REQUEST FOR EXAMINATION (FORM-18) [28-03-2025(online)].pdf | 2025-03-28 |
| 6 | 202517029724-PROOF OF RIGHT [28-03-2025(online)].pdf | 2025-03-28 |
| 7 | 202517029724-PRIORITY DOCUMENTS [28-03-2025(online)].pdf | 2025-03-28 |
| 8 | 202517029724-POWER OF AUTHORITY [28-03-2025(online)].pdf | 2025-03-28 |
| 9 | 202517029724-FORM 18 [28-03-2025(online)].pdf | 2025-03-28 |
| 10 | 202517029724-FORM 1 [28-03-2025(online)].pdf | 2025-03-28 |
| 11 | 202517029724-FIGURE OF ABSTRACT [28-03-2025(online)].pdf | 2025-03-28 |
| 12 | 202517029724-DRAWINGS [28-03-2025(online)].pdf | 2025-03-28 |
| 13 | 202517029724-DECLARATION OF INVENTORSHIP (FORM 5) [28-03-2025(online)].pdf | 2025-03-28 |
| 14 | 202517029724-COMPLETE SPECIFICATION [28-03-2025(online)].pdf | 2025-03-28 |
| 15 | 202517029724-Proof of Right [23-05-2025(online)].pdf | 2025-05-23 |
| 16 | 202517029724-MARKED COPY [13-06-2025(online)].pdf | 2025-06-13 |
| 17 | 202517029724-CORRECTED PAGES [13-06-2025(online)].pdf | 2025-06-13 |
| 18 | 202517029724-Proof of Right [16-06-2025(online)].pdf | 2025-06-16 |
| 19 | 202517029724-Others-180625.pdf | 2025-06-24 |
| 20 | 202517029724-Others-180625-1.pdf | 2025-06-24 |
| 21 | 202517029724-GPA-180625.pdf | 2025-06-24 |
| 22 | 202517029724-Correspondence-180625.pdf | 2025-06-24 |
| 23 | 202517029724-FORM 3 [27-08-2025(online)].pdf | 2025-08-27 |